{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:27:58Z","timestamp":1792801678150,"version":"4.5.0"},"reference-count":44,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Histopathology"],"published-print":{"date-parts":[[2008,7]]},"abstract":"<jats:p><jats:bold>Aims:\u2002<\/jats:bold> Despite the well\u2010established function of prolactin (PRL) in normal breast development, its role in breast cancer pathogenesis is still controversial. PRL activity is dependent on the activation of a transmembrane protein, the PRL receptor (PRLR). The aim was to evaluate and compare PRLR expression in gynaecomastia and male breast carcinoma (MBC).<\/jats:p><jats:p><jats:bold>Methods and results:\u2002<\/jats:bold> PRLR expression was detected immunohistochemically in 30 cases of gynaecomastia and 30 cases of MBC. The whole series was also assessed for oestrogen receptors (ER), progesterone receptors (PR) and androgen receptors (AR). A cut\u2010off of 10% was used as the criterion for positivity. Histological type and tumour differentiation were evaluated. Pathological stage was assessed [Tumour Node Metastasis (TNM)\u2010International Union Against Cancer system]. Statistical analysis was performed with Fisher\u2019s exact test. PRLR positivity was seen in 20% of gynaecomastia cases and in 60% of MBC cases (<jats:italic>P<\/jats:italic>\u2003=\u20030.003). In gynaecomastia immunoreactivity was predominantly observed in luminal cell borders, whereas in MBC the reactivity was heterogeneous and mainly cytoplasmic. There was no statistically significant correlation between PRLR expression and ER, PR, AR, pTNM, or histological grade.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> PRLR is significantly more expressed in MBC than in gynaecomastia, and with different patterns of reactivity, suggesting a role for PRL in male breast carcinogenesis.<\/jats:p>","DOI":"10.1111\/j.1365-2559.2008.03059.x","type":"journal-article","created":{"date-parts":[[2008,6,19]],"date-time":"2008-06-19T07:45:00Z","timestamp":1213861500000},"page":"56-61","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Prolactin receptor expression in gynaecomastia and male breast carcinoma"],"prefix":"10.1111","volume":"53","author":[{"given":"M","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mesquita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Quaresma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"354","article-title":"Detection of prolactin messenger RNA in mammary and other normal and neoplastic tissues by polymerase chain reaction","volume":"68","author":"Fields K","year":"1993","journal-title":"Lab. Invest."},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.138.12.5605"},{"key":"e_1_2_6_4_2","first-page":"695","article-title":"Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine\/paracrine loop","volume":"146","author":"Clevenger C","year":"1995","journal-title":"Am. J. Pathol."},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1006\/gcen.2001.7746"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-126-1-88"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015770423167"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.12.7567"},{"key":"e_1_2_6_9_2","first-page":"951","article-title":"Prolactin and murine mammary tumorigenesis: a review","volume":"37","author":"Welsch CW","year":"1977","journal-title":"Cancer Res."},{"key":"e_1_2_6_10_2","first-page":"4054","article-title":"Prolactin and the development and progression of early neoplastic mammary gland lesions","volume":"38","author":"Welsch CW","year":"1978","journal-title":"Cancer Res."},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119820"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206619"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209838"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3369"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1870"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2001-0036"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/me.16.1.45"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205637"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(81)90308-3"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203846"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1023956223037"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601947"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-12-3-235"},{"key":"e_1_2_6_24_2","first-page":"813","article-title":"In vivo studies of the anti\u2010tumor effects of a human prolactin antagonist, hPRL\u2010G129R","volume":"20","author":"Chen NY","year":"2002","journal-title":"Int. J. Oncol."},{"key":"e_1_2_6_25_2","first-page":"1381","article-title":"The role of human prolactin and its antagonist, G129R, in mammary gland development and DMBA\u2010initiated tumorigenesis in transgenic mice","volume":"27","author":"Tomblyn S","year":"2005","journal-title":"Int. J. Oncol."},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0270"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2004-0016"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980417)79:2<202::AID-IJC17>3.0.CO;2-B"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.54.12.956"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(86)90141-0"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.11.3692"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(88)90097-1"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(93)90178-I"},{"key":"e_1_2_6_34_2","first-page":"333","article-title":"Hormonal changes following hypophysectomy in humans","volume":"50","author":"Lachelin GC","year":"1977","journal-title":"Obstet. Gynecol."},{"key":"e_1_2_6_35_2","first-page":"1946","article-title":"Hormone binding by human mammary carcinoma","volume":"37","author":"Holdaway IM","year":"1977","journal-title":"Cancer Res."},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01806263"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910530403"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20312"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68226-3"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyl095"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1009546811429"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1080\/028418601750288190"},{"key":"e_1_2_6_43_2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5858\/2003-127-36-MVFB","article-title":"Male versus female breast cancer: a population\u2010based comparative immunohistochemical analysis","volume":"127","author":"Muir D","year":"2003","journal-title":"Arch. Pathol. Lab. Med."},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-006-9356-z"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2005.12.007"}],"container-title":["Histopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2559.2008.03059.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2559.2008.03059.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T16:54:21Z","timestamp":1697388861000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2559.2008.03059.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,28]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["10.1111\/j.1365-2559.2008.03059.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2559.2008.03059.x","archive":["Portico"],"relation":{},"ISSN":["0309-0167","1365-2559"],"issn-type":[{"value":"0309-0167","type":"print"},{"value":"1365-2559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,28]]},"assertion":[{"value":"2008-06-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}